mesalazine

Poland

Drugs containing this active substance

  • ASAMAX 250

    The medicine is used in the treatment of ulcerative colitis (mild to moderate) and Crohn's disease involving the colon. It helps to inhibit the progression of the disease process in the intestines during both the acute phase and the remission phase.

    Form: tablets, enteric-coated

    Active substance Dosage
    mesalazine 250 mg

    ATC: A07EC02

    Manufacturer: Sever Pharma Solutions AB

  • ASAMAX 250

    The medicine is used to treat ulcerative proctitis. It acts anti-inflammatorily directly on the diseased lesions in the intestinal tissue.

    Form: suppositories

    Active substance Dosage
    mesalazine 250 mg

    ATC: A07EC02

    Manufacturer: Temmler Italia S.R.L.

  • ASAMAX 500

    The medicine is used for the treatment of ulcerative colitis (mild to moderate, in both acute phase and remission) and Crohn's disease involving the colon (also in acute phase and remission).

    Form: tablets, enteric-coated

    Active substance Dosage
    mesalazine 500 mg

    ATC: A07EC02

    Manufacturer: Sever Pharma Solutions AB

  • ASAMAX 500

    The medicine is used to treat ulcerative proctitis. It acts anti-inflammatorily directly on the diseased lesions in the intestinal tissue.

    Form: suppositories

    Active substance Dosage
    mesalazine 500 mg

    ATC: A07EC02

    Manufacturer: Temmler Italia S.R.L.

  • CROHNAX

    It is used in the treatment of ulcerative colitis where the lesions are located in the rectum. It has an anti-inflammatory effect on the rectal wall.

    Form: suppositories

    Active substance Dosage
    mesalazine 1000 mg

    ATC: A07EC02

    Manufacturer: Farmina Sp. z o.o.

  • CROHNAX

    It is used in the treatment of ulcerative colitis where the lesions are located in the rectum. It acts anti-inflammatorily on the rectal wall.

    Form: suppositories

    Active substance Dosage
    mesalazine 500 mg

    ATC: A07EC02

    Manufacturer: Farmina Sp. z o.o.

  • GRANMESA

    The medicine is used to treat mild to moderate ulcerative colitis and Crohn's disease.

    Form: granules, prolonged-release in sachet

    Active substance Dosage
    mesalazine 1000 mg

    ATC: A07EC02

    Manufacturer: ATHENA IPS

  • GRANMESA

    The medicine is used to treat mild to moderate ulcerative colitis and Crohn's disease.

    Form: granules, prolonged-release in sachet

    Active substance Dosage
    mesalazine 2000 mg

    ATC: A07EC02

    Manufacturer: ATHENA IPS

  • MEZAVANT

    The medicine is used for the treatment of ulcerative colitis. It helps to relieve inflammation and symptoms during disease flare-ups, and may also be used to prevent recurrences.

    Form: tablets, delayed-release

    Active substance Dosage
    mesalazine 1200 mg

    ATC: A07EC02

    Manufacturer: Cosmo SpA

  • PENTASA

    It is used in the treatment of ulcerative proctitis. It acts locally as an anti-inflammatory on the rectal wall.

    Form: suppositories, rectal

    Active substance Dosage
    mesalazine 1000 mg

    ATC: A07EC02

    Manufacturer: Ferring GmbH

  • PENTASA

    The medicine is used to treat mild to moderate ulcerative colitis and Crohn's disease.

    Form: tablets, prolonged release

    Active substance Dosage
    mesalazine 500 mg

    ATC: A07EC02

    Manufacturer: Ferring GmbH

  • PENTASA

    The medicine is used for the treatment of ulcerative colitis and proctitis. It acts locally as an anti-inflammatory on the diseased intestinal wall.

    Form: suspension, rectal

    Active substance Dosage
    mesalazine 1 g

    ATC: A07EC02

    Manufacturer: Ferring Lečiva a.s.

  • PENTASA

    The medicine is used in the treatment of mild to moderate ulcerative colitis and Crohn's disease.

    Form: granules, prolonged release

    Active substance Dosage
    mesalazine 2000 mg

    ATC: A07EC02

    Manufacturer: Ferring GmbH

  • PENTASA

    It is used in the treatment of mild to moderate ulcerative colitis and Crohn's disease.

    Form: tablets, prolonged release

    Active substance Dosage
    mesalazine 1000 mg

    ATC: A07EC02

    Manufacturer: Ferring GmbH

  • PENTASA

    The medicine is used to treat mild to moderate ulcerative colitis and Crohn's disease.

    Form: granules, prolonged release

    Active substance Dosage
    mesalazine 4 g

    ATC: A07EC02

    Manufacturer: Ferring GmbH

  • SALAZA

    The medicine is used in the treatment of ulcerative colitis (inflammatory bowel disease).

    Form: tablets, enteric-coated

    Active substance Dosage
    mesalazine 500 mg

    ATC: A07EC02

    Manufacturer: Faes Farma S.A.

  • SALAZA

    The medicine is used for the treatment of ulcerative colitis of the distal colon (large intestine and rectum). It helps both in the treatment of the exacerbation phase of mild to moderate severity and in maintaining remission.

    Form: suppositories

    Active substance Dosage
    mesalazine 500 mg

    ATC: A07EC02

    Manufacturer: Faes Farma Portugal S.A.

  • SALAZA

    The medicine is used to treat ulcerative colitis of the distal colon (large intestine and rectum). It helps both in relieving the exacerbation phase of the disease and in maintaining remission.

    Form: suppositories

    Active substance Dosage
    mesalazine 1000 g

    ATC: A07EC02

    Manufacturer: Faes Farma Portugal S.A.

  • SALAZA

    The medicine is used in the treatment of ulcerative colitis (inflammatory bowel disease).

    Form: tablets, enteric-coated

    Active substance Dosage
    mesalazine 1000 mg

    ATC: A07EC02

    Manufacturer: Faes Farma S.A.

  • SALOFALK

    The medicine is used to treat acute flares of ulcerative colitis. It acts locally as an anti-inflammatory on the mucosa and tissue of the large intestine.

    Form: suspension, rectal

    Active substance Dosage
    mesalazine 4 mg

    ATC: A07EC02

    Manufacturer: Dr. Falk Pharma GmbH

  • SALOFALK

    The medicinal product is used for the treatment of acute episodes and the prevention of relapses of mild to moderate ulcerative colitis and inflammatory bowel disease (colitis).

    Form: granules, extended release for oral use

    Active substance Dosage
    mesalazine 1.5 g

    ATC: A07EC02

    Manufacturer: Dr. Falk Pharma GmbH

  • SALOFALK

    Salofalk is used for the treatment of acute episodes and the prevention of relapses of mild to moderate ulcerative colitis and inflammatory bowel disease (colitis).

    Form: granules, extended release for oral use

    Active substance Dosage
    mesalazine 3 g

    ATC: A07EC02

    Manufacturer: Dr. Falk Pharma GmbH

  • SALOFALK

    The medicine is used for the treatment of acute episodes and the prevention of relapses of mild to moderate ulcerative colitis and inflammatory bowel disease (colitis).

    Form: granules, extended release for oral use

    Active substance Dosage
    mesalazine 1000 mg

    ATC: A07EC02

    Manufacturer: Dr. Falk Pharma GmbH

  • SALOFALK 1 G

    The medicine is used to treat acute episodes of mild to moderate ulcerative colitis or proctitis limited to the rectum.

    Form: suppositories

    Active substance Dosage
    mesalazine 1000 mg

    ATC: A07EC02

    Manufacturer: Dr. Falk Pharma GmbH

  • SALOFALK 500

    The medicine is used in the treatment of ulcerative colitis (during flare-ups and to prevent relapses) and in Crohn's disease (during flare-ups).

    Form: tablets, enteric-coated

    Active substance Dosage
    mesalazine 500 mg

    ATC: A07EC02

    Manufacturer: Dr. Falk Pharma GmbH

  • SALOFALK 500

    The medicine is used during the flare-up phase of ulcerative proctitis.

    Form: suppositories

    Active substance Dosage
    mesalazine 500 mg

    ATC: A07EC02

    Manufacturer: Dr. Falk Pharma GmbH